StockData
Baxter International Inc logo

Baxter International Inc (BAX) shareholders

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/305% above fair value
$25.76+0.22 (+0.86%)

Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
557M of 517M shares
Institutional holders
685
106 new, 74 sold out
Net institutional buying
28M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Pzena Investment Management LLC65,347,62112.70%13G (passive) amendmentMar 31, 2026
Dodge & Cox57,396,37011.20%13G (passive) amendmentSep 30, 2025
Abigail P. Johnson
Joint filing with FMR LLC (10.30%)
52,972,91410.30%13G (passive) amendmentMay 29, 2026
Vanguard Capital Management38,033,9077.36%13G (passive)Mar 31, 2026
BlackRock, Inc.33,109,8526.40%13G (passive) amendmentMar 31, 2026
BlackRock Portfolio Management LLC30,382,6535.90%13G (passive) amendmentSep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BAXValueChange% of portfolio
BlackRock, Inc.81,842,10515.82%$1.74B+2,441,4410.03%
Pzena Investment Management LLC65,295,39312.62%$1.39B+767,5704.09%
Dodge & Cox58,386,34511.29%$1.24B+1,131,7750.65%
FMR LLC53,913,83110.42%$1.15B+7,649,0270.05%
Vanguard Capital Management LLC33,754,2806.52%$719.64M+247,3050.02%
Vanguard Portfolio Management LLC24,057,1904.65%$512.90M+63,8350.02%
State Street Corp20,600,4683.98%$439.40M+620,5110.01%
Greenhaven Associates Inc14,285,2282.76%$304.56M−22,4603.52%
Geode Capital Management, LLC14,123,6892.73%$300.59M+360,7240.02%
Invesco Ltd.12,361,8812.39%$263.56M−759,2900.02%
UBS Group AG9,529,3091.84%$203.16M+5,209,8120.03%
First Pacific Advisors, LP7,618,1451.47%$162.42M+917,2202.01%
Goldman Sachs Group Inc7,150,4621.38%$152.45M+3,280,9070.01%
Equity Investment Corp6,886,2651.33%$146.82M+516,2712.80%
Morgan Stanley6,359,7901.23%$135.59M−988,1820.01%
Bank Of America Corp /De/6,237,9501.21%$132.99M+71,8170.01%
State Farm Mutual Automobile Insurance Co6,225,0601.20%$132.72M–0.09%
Charles Schwab Investment Management Inc5,996,7111.16%$127.85M+407,1570.02%
Dimensional Fund Advisors LP5,612,1441.08%$119.68M−319,6470.02%
Northern Trust Corp4,864,0040.94%$103.70M+516,6860.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026685557M100.0%106 / 250194 / 7448M21M
Q1 2026662529M100.0%82 / 190261 / 120114M74M
Q4 2025710552M100.0%112 / 240237 / 12091M48M
Q3 2025732510M98.5%87 / 252269 / 11681M69M
Q2 2025774500M96.7%71 / 266298 / 12731M22M
Q1 2025841491M95.0%124 / 277305 / 9636M26M
Q4 2024824483M93.3%114 / 250333 / 17046M36M
Q3 2024899475M91.7%121 / 305320 / 93109M33M
Q2 2024879462M89.2%98 / 278324 / 14045M61M
Q1 2024935479M92.5%115 / 313322 / 7929M25M
Q4 2023913475M91.9%127 / 262376 / 11175M48M
Q3 2023909448M86.7%77 / 285378 / 13361M53M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

476 funds held BAX in Q2 2026, 37% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BAXValue% of fundAs of
Dodge & Cox Stock Fund38,623,7007.47%$823.46M0.70%Jun 30, 2026
BlackRock Equity Dividend Fund18,965,2213.67%$496.13M2.43%Jul 31, 2026
Vanguard Total Stock Market Index Fund16,397,1623.17%$349.59M0.02%Jun 30, 2026
Vanguard 500 Index Fund13,382,9132.59%$285.32M0.02%Jun 30, 2026
Vanguard Small-Cap Index Fund11,833,1282.29%$252.28M0.13%Jun 30, 2026
Vanguard Windsor Fund10,439,5982.02%$273.10M1.08%Jul 31, 2026
Invesco S&P 500 Equal Weight ETF9,173,9881.77%$239.99M0.25%Jul 31, 2026
Fidelity Series Large Cap Stock Fund8,971,2141.73%$191.27M0.66%Jun 30, 2026
Vanguard Small-Cap Value Index Fund7,499,9861.45%$159.90M0.24%Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund7,153,0181.38%$134.33M0.05%May 31, 2026
iShares Core S&P 500 ETF7,103,3591.37%$151.44M0.02%Jun 30, 2026
Fidelity 500 Index Fund6,583,9651.27%$123.65M0.01%May 31, 2026
Fidelity Growth and Income Portfolio4,824,8000.93%$126.22M0.85%Jul 31, 2026
FPA Crescent Fund4,541,1660.88%$96.82M0.78%Jun 30, 2026
Vanguard Selected Value Fund3,672,4380.71%$96.07M1.38%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Andrew P. HiderPresident and CEO, Director518,4470.10%Sep 3, 2026
Terence John RogersEVP and CFO0–Oct 2, 2026
Bernard HeineAVP, Finance InterimCAO&Cntrlr32,8400.01%Sep 18, 2026
James TeaffPresident, CCS30,3700.01%Sep 3, 2026
Julie FosterPresident, Front Line Care29,1640.01%Sep 3, 2026
Steven P. WallacePresident, Adv. Surgery70,1280.01%Jun 3, 2026
Anita A. ZielinskiSVP, Interim CFO, CAO & Cntrlr59,7140.01%Jun 3, 2026
Maria Cecilia SorianoGroup Pres., ITT & Pharma.75,0450.01%Mar 10, 2026
Joel T. GradeEVP and CFO271,6740.05%Mar 10, 2026
David S. RosenbloomEVP and General Counsel138,2160.03%Mar 10, 2026
Reazur RasulEVP,Group Pres,Healthcare125,5570.02%Mar 10, 2026
Cynthia CarlisleExecutive Vice President, CHRO0–Mar 3, 2026
Jeanne K. MasonEVP, Chief HR Officer199,8530.04%Dec 16, 2025
James W. BorziEVP,Chief Supply Chain Officer71,9480.01%Sep 4, 2025
Alok SonigEVP,Group President,Pharma128,2190.02%Sep 4, 2025
Heather KnightEVP, Chief Operating Officer177,3620.03%Mar 10, 2025
Christopher A. TothEVP, Group Pres, Kidney Care105,1860.02%Feb 4, 2025
Jose E. AlmeidaChairman, CEO, President568,5650.11%Dec 17, 2024
Michael R. McDonnellDirector14,6470.00%May 7, 2026
Patricia MorrisonDirector42,3860.01%May 7, 2026
Nancy M. SchlichtingDirector34,9940.01%May 7, 2026
Jeffrey A. CraigDirector23,6620.00%May 7, 2026
David S. WilkesDirector37,0760.01%May 7, 2026
David Brent ShaferDirector72,8040.01%May 7, 2026
William A. Ampofo IIDirector30,3750.01%May 7, 2026
Amy McBride WendellDirector44,2350.01%May 7, 2026
Cathy R. SmithDirector30,3450.01%May 8, 2025
Stephen H. RusckowskiDirector16,4990.00%May 8, 2025
Stephen N. OesterleDirector35,8470.01%May 8, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Julie Foster
President, Front Line Care
Sep 2, 2026Tax withholding−2,098$25.70$53.92K29,164
Andrew P. Hider
President and CEO, Director
Sep 2, 2026Tax withholding−54,276$25.70$1.39M518,447
James Teaff
President, CCS
Sep 1, 2026Tax withholding−750$25.48$19.11K30,370
Steven P. Wallace
President, Adv. Surgery
Jun 2, 2026Tax withholding−153$18.68$2.86K70,128
James Teaff
President, CCS
Jun 2, 2026Tax withholding−321$18.68$6.00K31,063
Anita A. Zielinski
SVP, Interim CFO, CAO & Cntrlr
Jun 1, 2026Award+13,426––59,714
Patricia Morrison
Director
May 5, 2026Award+12,836––42,386
Nancy M. Schlichting
Director
May 5, 2026Award+12,836––34,994
Jeffrey A. Craig
Director
May 5, 2026Award+12,836––23,662
David S. Wilkes
Director
May 5, 2026Award+12,836––37,076
David Brent Shafer
Director
May 5, 2026Award+12,836––72,804
William A. Ampofo II
Director
May 5, 2026Award+12,836––30,375
Amy McBride Wendell
Director
May 5, 2026Award+12,836––44,235
Michael R. McDonnell
Director
May 5, 2026Award+12,836––14,647
Joel T. Grade
EVP and CFO
Mar 6, 2026Tax withholding−8,153$17.69$144.23K271,674
Reazur Rasul
EVP,Group Pres,Healthcare
Mar 6, 2026Tax withholding−12,674$17.69$224.20K125,557
Anita A. Zielinski
SVP, CAO and Controller
Mar 6, 2026Tax withholding−1,932$17.69$34.18K46,281
Maria Cecilia Soriano
Group Pres., ITT & Pharma.
Mar 6, 2026Tax withholding−2,848$17.69$50.38K75,045
David S. Rosenbloom
EVP and General Counsel
Mar 6, 2026Tax withholding−6,620$17.69$117.11K138,216
David S. Rosenbloom
EVP and General Counsel
Mar 2, 2026Tax withholding−1,336$19.69$26.31K144,837
Maria Cecilia Soriano
Group Pres., ITT & Pharma.
Mar 2, 2026Tax withholding−1,852$19.69$36.47K77,894
Reazur Rasul
EVP,Group Pres,Healthcare
Mar 2, 2026Tax withholding−1,614$19.69$31.78K138,231
Andrew P. Hider
President and CEO, Director
Feb 27, 2026Award+201,804––572,239
Anita A. Zielinski
SVP, CAO and Controller
Feb 27, 2026Award+30,864––48,214
David S. Rosenbloom
EVP and General Counsel
Feb 27, 2026Award+26,709––146,173
Joel T. Grade
EVP and CFO
Feb 27, 2026Award+42,735––279,828
Maria Cecilia Soriano
Group Pres., ITT & Pharma.
Feb 27, 2026Award+23,742––79,748
Cynthia Carlisle
Executive Vice President, CHRO
Feb 27, 2026Award+11,871––29,677
Cynthia Carlisle
Executive Vice President, CHRO
Feb 27, 2026Award+17,806––17,806
Michael R. McDonnell
Director
Feb 13, 2026Award+1,811––1,811
Joel T. Grade
EVP and CFO
Feb 9, 2026Award+30,504––246,048
Joel T. Grade
EVP and CFO
Feb 9, 2026Tax withholding−9,144$21.73$198.70K236,904
Maria Cecilia Soriano
Group Pres., ITT & Pharma.
Feb 9, 2026Tax withholding−918$21.73$19.95K56,006
Maria Cecilia Soriano
Group Pres., ITT & Pharma.
Feb 9, 2026Award+2,273––56,924
David S. Rosenbloom
EVP and General Counsel
Feb 9, 2026Award+17,055––124,689
David S. Rosenbloom
EVP and General Counsel
Feb 9, 2026Tax withholding−5,225$21.73$113.54K119,464
Reazur Rasul
EVP,Group Pres,Healthcare
Feb 9, 2026Tax withholding−5,770$21.73$125.38K139,846
Reazur Rasul
EVP,Group Pres,Healthcare
Feb 9, 2026Award+18,951––145,616
Jeanne K. Mason
EVP, Chief HR Officer
Dec 12, 2025Tax withholding−650$19.15$12.45K199,853
Joel T. Grade
EVP and CFO
Dec 1, 2025Tax withholding−8,288$19.08$158.14K215,151
Alok Sonig
EVP,Group President,Pharma
Sep 2, 2025Tax withholding−3,191$24.17$77.13K128,219
James W. Borzi
EVP,Chief Supply Chain Officer
Sep 2, 2025Tax withholding−1,848$24.17$44.67K71,948
Joel T. Grade
EVP and CFO
Sep 2, 2025Award+102,712––222,560
Andrew P. Hider
President and CEO, Director
Sep 2, 2025Award+131,813––368,050
Andrew P. Hider
President and CEO, Director
Sep 2, 2025Award+236,237––236,237
David Brent Shafer
Director
Aug 19, 2025Tax withholding−31,337$24.33$762.43K59,446
David S. Rosenbloom
EVP and General Counsel
Jun 2, 2025Tax withholding−16,548$29.55$488.99K106,327
William A. Ampofo II
Director
May 6, 2025Award+7,183––17,299
Cathy R. Smith
Director
May 6, 2025Award+7,183––30,345
Amy McBride Wendell
Director
May 6, 2025Award+7,183––31,222
David S. Wilkes
Director
May 6, 2025Award+7,183––23,906
Stephen N. Oesterle
Director
May 6, 2025Award+7,183––35,847
Stephen H. Rusckowski
Director
May 6, 2025Award+7,183––16,499
Patricia Morrison
Director
May 6, 2025Award+7,183––29,137
Nancy M. Schlichting
Director
May 6, 2025Award+7,183––21,850
Jeffrey A. Craig
Director
May 6, 2025Award+7,183––10,672
David S. Rosenbloom
EVP and General Counsel
Mar 6, 2025Tax withholding−4,922$35.44$174.44K104,780
David S. Rosenbloom
EVP and General Counsel
Mar 6, 2025Award+17,658––122,438
Alok Sonig
EVP,Group President,Pharma
Mar 6, 2025Award+29,966––130,298
Alok Sonig
EVP,Group President,Pharma
Mar 6, 2025Tax withholding−10,839$35.44$384.13K100,332

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.60%
24M shares short
Days to cover
3.0
At 8M shares a day
Change since last report
-0.4%
From 24M shares
Short volume, 20 days
60.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Baxter International's stock actually held short. Settlement fails (shares not delivered on time) peaked at 113,283 shares on Oct 2, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Stephen N. Oesterle Rev Trust
Former Affiliate
May 18, 202636,347$645.24KMay 18, 2026Open Market Purchase
Brian Stevens
Officer
Sep 16, 2024976$39.05KSep 16, 2024OTHER SP SHARES
Brian Stevens
Officer
Sep 13, 202416,063$639.46KSep 13, 2024PERFORMANCE SHARES
Jeanne K. Mason
Officer
Mar 1, 202464,488$2.62MMar 1, 2024Stock Option Exercise

Congress trades

40 trades in Baxter International reported by 17 members of the House

MemberTypeTradedAmountFiled
Michael T. McCaul
TX10 · spouse
BoughtJan 13, 2026$50K–100KFeb 11, 2026
Lisa McClain
MI09 · spouse
SoldOct 31, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
SoldOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtSep 25, 2025$1K–15KOct 22, 2025
Lisa McClain
MI09 · spouse
SoldAug 4, 2025$1K–15KSep 12, 2025
Lisa McClain
MI09 · spouse
BoughtJul 22, 2025$1K–15KAug 13, 2025
Rob Bresnahan
PA08
BoughtMay 15, 2025$1K–15KJun 9, 2025
Debbie Wasserman Schultz
FL25 · child
BoughtNov 18, 2024$1K–15KNov 20, 2024
Earl Blumenauer
OR03 · spouse
BoughtJul 9, 2024$15K–50KAug 6, 2024
Robert J. Wittman
VA01
SoldJan 20, 2023$1K–15KFeb 15, 2023
William R. Keating
MA09
SoldDec 5, 2022$1K–15KDec 21, 2022
Robert J. Wittman
VA01
BoughtJul 15, 2022$1K–15KAug 10, 2022
Robert J. Wittman
VA01
Sold (part)Jun 16, 2022$1K–15KJul 8, 2022
William R. Keating
MA09
BoughtApr 14, 2021$1K–15KApr 27, 2021
William R. Keating
MA09
BoughtMar 17, 2021$1K–15KApr 27, 2021
Peter Meijer
MI03
SoldFeb 16, 2021$1K–15KMar 16, 2021
Dean Phillips
MN03
Sold (part)Dec 18, 2020$1K–15KJan 9, 2021
Dean Phillips
MN03
BoughtSep 23, 2020$1K–15KOct 9, 2020
Lois Frankel
FL22
SoldMay 27, 2020$1K–15KJun 28, 2020
Dean Phillips
MN03
BoughtApr 2, 2020$1K–15KMay 7, 2020
Dean Phillips
MN03
BoughtFeb 28, 2020$1K–15KMar 12, 2020
Lois Frankel
FL22
Sold (part)Jan 29, 2020$1K–15KFeb 24, 2020
Dean Phillips
MN03
SoldNov 22, 2019$1K–15KDec 11, 2019
Dean Phillips
MN03
Sold (part)Sep 11, 2019$1K–15KOct 11, 2019
Dean Phillips
MN03
BoughtAug 13, 2019$1K–15KSep 16, 2019
Lois Frankel
FL22
Sold (part)Feb 28, 2019$1K–15KMar 27, 2019
Susie Lee
NV03 · joint account
SoldFeb 27, 2019$1K–15KMar 12, 2019
Lois Frankel
FL22
Sold (part)Jul 18, 2018$1K–15KAug 24, 2018
Gary Palmer
AL06 · spouse
SoldNov 27, 2017$1K–15KSep 29, 2018
306 days late
Richard L. Hanna
NY22
SoldDec 28, 2016$15K–50KJan 18, 2017
Mo Brooks
AL05 · joint account
SoldAug 31, 2016$1K–15KOct 10, 2016
Lois Frankel
FL22
BoughtJan 15, 2016$1K–15KFeb 29, 2016
Lois Frankel
FL22
BoughtJan 15, 2016$1K–15KJan 28, 2016
Lois Frankel
FL22
BoughtNov 23, 2015$1K–15KJan 8, 2016
46 days late
Raúl M. Grijalva
AZ03
SoldOct 15, 2015$1K–15KNov 2, 2015
K. Michael Conaway
TX11 · joint account
SoldJul 31, 2015$1K–15KAug 3, 2015
K. Michael Conaway
TX11
SoldJul 31, 2015$1K–15KAug 3, 2015
Frank A. LoBiondo
NJ02
SoldJul 30, 2015$1K–15KJul 20, 2016
356 days late
Raúl M. Grijalva
AZ03
BoughtJul 29, 2015$1K–15KAug 13, 2015

See a number that looks wrong?